Cellectis SA (CLLS)
1.86
-0.05
(-2.62%)
USD |
NASDAQ |
Nov 21, 16:00
1.88
+0.02
(+1.08%)
After-Hours: 20:00
Cellectis Price to Book Value: 1.438 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.438 |
| November 20, 2024 | 1.477 |
| November 19, 2024 | 1.516 |
| November 18, 2024 | 1.500 |
| November 15, 2024 | 1.446 |
| November 14, 2024 | 1.477 |
| November 13, 2024 | 1.531 |
| November 12, 2024 | 1.527 |
| November 11, 2024 | 1.477 |
| November 08, 2024 | 1.369 |
| November 07, 2024 | 1.353 |
| November 06, 2024 | 1.369 |
| November 05, 2024 | 1.377 |
| November 04, 2024 | 1.361 |
| November 01, 2024 | 1.392 |
| October 31, 2024 | 1.377 |
| October 30, 2024 | 1.408 |
| October 29, 2024 | 1.415 |
| October 28, 2024 | 1.493 |
| October 25, 2024 | 1.438 |
| October 24, 2024 | 1.469 |
| October 23, 2024 | 1.524 |
| October 22, 2024 | 1.392 |
| October 21, 2024 | 1.419 |
| October 18, 2024 | 1.469 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.477 |
| October 16, 2024 | 1.469 |
| October 15, 2024 | 1.462 |
| October 14, 2024 | 1.508 |
| October 11, 2024 | 1.554 |
| October 10, 2024 | 1.547 |
| October 09, 2024 | 1.508 |
| October 08, 2024 | 1.516 |
| October 07, 2024 | 1.524 |
| October 04, 2024 | 1.465 |
| October 03, 2024 | 1.531 |
| October 02, 2024 | 1.516 |
| October 01, 2024 | 1.562 |
| September 30, 2024 | 1.640 |
| September 27, 2024 | 1.471 |
| September 26, 2024 | 1.475 |
| September 25, 2024 | 1.455 |
| September 24, 2024 | 1.488 |
| September 23, 2024 | 1.482 |
| September 20, 2024 | 1.520 |
| September 19, 2024 | 1.563 |
| September 18, 2024 | 1.536 |
| September 17, 2024 | 1.576 |
| September 16, 2024 | 1.549 |
| September 13, 2024 | 1.515 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5691
Minimum
Jun 16 2022
5.012
Maximum
Jan 19 2021
1.862
Average
1.736
Median
Price to Book Value Benchmarks
| Edap TMS SA | 1.940 |
| DBV Technologies SA | 0.869 |
| Genfit SA | 2.028 |
| Adaptimmune Therapeutics PLC | 2.036 |
| Akari Therapeutics PLC | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.732 |
| Price to Free Cash Flow | 2.760 |
| Price | 1.86 |
| Earnings Yield | -72.04% |
| Market Cap | 186.17M |